Serial assessment of spot urine sodium predicts effectiveness of decongestion and outcome in patients with acute heart failure.
Acute Disease
Administration, Intravenous
Aged
Edema, Cardiac
/ physiopathology
Female
Furosemide
/ therapeutic use
Heart Failure
/ drug therapy
Hepatitis A Virus Cellular Receptor 1
/ metabolism
Hospitalization
Humans
Lipocalin-2
/ urine
Male
Middle Aged
Prognosis
Prospidium
Sodium
/ urine
Sodium Potassium Chloride Symporter Inhibitors
/ therapeutic use
Treatment Outcome
Acute heart failure
Decongestion
Kidney injury
Mortality
Urine sodium
Journal
European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
27
09
2018
revised:
03
12
2018
accepted:
04
01
2019
pubmed:
19
2
2019
medline:
10
9
2020
entrez:
19
2
2019
Statut:
ppublish
Résumé
The clinical significance of the measurement of urine sodium concentration (UNa We enrolled 111 AHF patients, all of whom received intravenous furosemide on admission. The mean spot UNa In AHF, low spot UNa+ and lack to increase UNa
Substances chimiques
HAVCR1 protein, human
0
Hepatitis A Virus Cellular Receptor 1
0
LCN2 protein, human
0
Lipocalin-2
0
Sodium Potassium Chloride Symporter Inhibitors
0
Furosemide
7LXU5N7ZO5
Prospidium
7Y2M0915RZ
Sodium
9NEZ333N27
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
624-633Subventions
Organisme : Department of Heart Diseases, Wroclaw Medical University, Poland
ID : ST-905
Pays : International
Informations de copyright
© 2019 The Authors. European Journal of Heart Failure © 2019 European Society of Cardiology.